MDxHealth
In Brief This Week: Accelerate Diagnostics, MDxHealth, Mayo Clinic; Sysmex America, More
News items for the week of Jan. 13, 2025.
360Dx Top 30 Rebounds in 2024, Rises 4 Percent
Of the 30 companies in the index, 16 saw their share prices rise, while 14 saw their share prices decline.
Updated NCCN Guidelines Adjust Ratings for Prostate Cancer Genetic Tests
The newest version ups its endorsement of somatic genomic testing to "recommended" for advanced cancers and shifts its recommendations on early-stage risk assays.
MDxHealth Raises Full-Year Guidance as Revenues Increase 21 Percent in Q3
Tissue-based tests comprised 80 percent of the firm's Q3 revenues, while volumes in that category rose 36 percent year over year.
360Dx Top 30 Inches up 1 Percent in September
Of the 30 companies in the index, 13 saw their stock prices increase, 15 saw their share prices decline, and two firms' stock prices remained essentially flat.
Sep 25, 2024
MDxHealth Prices $40M Ordinary Share Public Offering
Aug 22, 2024
MDxHealth Q2 Revenues Rise 33 Percent
Apr 1, 2024
360Dx Top 30 Rises 3 Percent in March
Apr 3, 2023
Feb 3, 2023